Literature DB >> 31411634

Risk Prediction Model in Children With Hypertrophic Cardiomyopathy: A Work in Progress.

Robert O Bonow1,2, Elizabeth M McNally1,3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31411634      PMCID： PMC7460721          DOI： 10.1001/jamacardio.2019.2945

Source DB:  PubMed          Journal:  JAMA Cardiol            Impact factor:   14.676


× No keyword cloud information.
  4 in total

1.  Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

Authors:  Martin S Maron; Ethan J Rowin; Benjamin S Wessler; Paula J Mooney; Amber Fatima; Parth Patel; Benjamin C Koethe; Mikhail Romashko; Mark S Link; Barry J Maron
Journal:  JAMA Cardiol       Date:  2019-07-01       Impact factor: 14.676

2.  Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids).

Authors:  Gabrielle Norrish; Tao Ding; Ella Field; Lidia Ziólkowska; Iacopo Olivotto; Giuseppe Limongelli; Aristides Anastasakis; Robert Weintraub; Elena Biagini; Luca Ragni; Terence Prendiville; Sophie Duignan; Karen McLeod; Maria Ilina; Adrián Fernández; Regina Bökenkamp; Anwar Baban; Peter Kubuš; Piers E F Daubeney; Georgia Sarquella-Brugada; Sergi Cesar; Chiara Marrone; Vinay Bhole; Constancio Medrano; Orhan Uzun; Elspeth Brown; Ferran Gran; Francisco J Castro; Graham Stuart; Gabriele Vignati; Roberto Barriales-Villa; Luis G Guereta; Satish Adwani; Katie Linter; Tara Bharucha; Pablo Garcia-Pavia; Torsten B Rasmussen; Margherita M Calcagnino; Caroline B Jones; Hans De Wilde; J Toru-Kubo; Tiziana Felice; Jens Mogensen; Sujeev Mathur; Zdenka Reinhardt; Constantinos O'Mahony; Perry M Elliott; Rumana Z Omar; Juan P Kaski
Journal:  JAMA Cardiol       Date:  2019-09-01       Impact factor: 14.676

3.  International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM).

Authors:  Constantinos O'Mahony; Fatima Jichi; Steve R Ommen; Imke Christiaans; Eloisa Arbustini; Pablo Garcia-Pavia; Franco Cecchi; Iacopo Olivotto; Hiroaki Kitaoka; Israel Gotsman; Gerald Carr-White; Jens Mogensen; Loizos Antoniades; Saidi A Mohiddin; Mathew S Maurer; Hak Chiaw Tang; Jeffrey B Geske; Konstantinos C Siontis; Karim D Mahmoud; Alexa Vermeer; Arthur Wilde; Valentina Favalli; Oliver P Guttmann; Maria Gallego-Delgado; Fernando Dominguez; Ilaria Tanini; Toru Kubo; Andre Keren; Teofila Bueser; Sarah Waters; Issa F Issa; James Malcolmson; Tom Burns; Neha Sekhri; Christopher W Hoeger; Rumana Z Omar; Perry M Elliott
Journal:  Circulation       Date:  2017-11-30       Impact factor: 29.690

4.  Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).

Authors:  Carolyn Y Ho; Sharlene M Day; Euan A Ashley; Michelle Michels; Alexandre C Pereira; Daniel Jacoby; Allison L Cirino; Jonathan C Fox; Neal K Lakdawala; James S Ware; Colleen A Caleshu; Adam S Helms; Steven D Colan; Francesca Girolami; Franco Cecchi; Christine E Seidman; Gautam Sajeev; James Signorovitch; Eric M Green; Iacopo Olivotto
Journal:  Circulation       Date:  2018-08-23       Impact factor: 29.690
  4 in total
  1 in total

1.  Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy.

Authors:  Giovanna Gallo; Vittoria Mastromarino; Giuseppe Limongelli; Giulio Calcagni; Antonello Maruotti; Luca Ragni; Fabio Valente; Maria Beatrice Musumeci; Rachele Adorisio; Marta Rubino; Camillo Autore; Damiano Magrì
Journal:  Biomolecules       Date:  2021-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.